Healthcare provider profile · identity verified

Julia Cuervo, M.D.

Internal Medicine · LOVELAND, CO · NPI 1275500787

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	669	187
Levothyroxine Sodium	Levothyroxine Sodium	455	116
Lisinopril	Lisinopril	312	81
Losartan Potassium	Losartan Potassium	216	60
Rosuvastatin Calcium	Rosuvastatin Calcium	185	57
Metoprolol Succinate	Metoprolol Succinate	176	53
Metformin Hcl Er	Metformin Hcl	172	46
Amlodipine Besylate	Amlodipine Besylate	171	49
Ezetimibe	Ezetimibe	152	40
Omeprazole	Omeprazole	142	41
Tamsulosin Hcl	Tamsulosin Hcl	131	34
Meloxicam	Meloxicam	120	42
Hydrochlorothiazide	Hydrochlorothiazide	118	32
Trazodone Hcl	Trazodone Hcl	118	35
Gabapentin	Gabapentin	117	39
Glipizide Er	Glipizide	112	33
Potassium Chloride	Potassium Chloride	103	32
Venlafaxine Hcl Er	Venlafaxine Hcl	101	24
Simvastatin	Simvastatin	97	25
Allopurinol	Allopurinol	93	25
Pravastatin Sodium	Pravastatin Sodium	86	25
Duloxetine Hcl	Duloxetine Hcl	75	16
Pantoprazole Sodium	Pantoprazole Sodium	75	24
Atenolol	Atenolol	71	16
Albuterol Sulfate Hfa	Albuterol Sulfate	68	27
Synthroid	Levothyroxine Sodium	65	17
Escitalopram Oxalate	Escitalopram Oxalate	64	21
Finasteride	Finasteride	59	11
Bupropion Xl	Bupropion Hcl	58	15
Famotidine	Famotidine	56	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	15
Sertraline Hcl	Sertraline Hcl	54	18
Furosemide	Furosemide	53	15
Zolpidem Tartrate	Zolpidem Tartrate	52	22
Tramadol Hcl	Tramadol Hcl	50	suppressed
Metformin Hcl	Metformin Hcl	49	14
Eliquis	Apixaban	47	suppressed
Clopidogrel	Clopidogrel Bisulfate	45	12
Metoprolol Tartrate	Metoprolol Tartrate	43	12
Jardiance	Empagliflozin	42	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Montelukast Sodium	Montelukast Sodium	37	suppressed
Ozempic	Semaglutide	37	suppressed
Alendronate Sodium	Alendronate Sodium	36	suppressed
Carvedilol	Carvedilol	35	12
Buspirone Hcl	Buspirone Hcl	34	suppressed
Spironolactone	Spironolactone	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Prednisone	Prednisone	29	23
Doxycycline Hyclate	Doxycycline Hyclate	26	23
Shingrix	Varicella-Zoster Ge/As01b/Pf	26	22
Azithromycin	Azithromycin	25	22
Rybelsus	Semaglutide	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	23	suppressed
Estradiol	Estradiol	22	11
Januvia	Sitagliptin Phosphate	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Methylprednisolone	Methylprednisolone	21	21
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Valsartan	Valsartan	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	18	18
Carbamazepine Er	Carbamazepine	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Nystatin	Nystatin	17	12
Memantine Hcl	Memantine Hcl	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Np Thyroid	Thyroid,pork	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Metolazone	Metolazone	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Propranolol Hcl	Propranolol Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Dilantin	Phenytoin Sodium Extended	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Topiramate	Topiramate	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error